Kohlberg Kravis Roberts & Co. L.P.
Reported holdings as of Q2 2026, from 31 quarterly filings.
This filer last reported in Q2 2026; the most recent quarter on file across all filers is Q3 2026. Firms that restructure stop filing under one CIK and start under another, so a successor entity may hold these positions now under a similar name.
Holdings
Download these holdings as CSV
| Security | Ticker | Value | Shares | Weight | Weight change | Held | Change |
|---|---|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SVCS INC | BTSG | $1.9B | 26,829,880 | -0.56pp | 10q | -35.9%-$1.0B | |
| SCHEIN HENRY INC | HSIC | $1.3B | 15,652,032 | +1.32pp | 6q | HELD | |
| BRIDGEBIO PHARMA INC | BBIO | $987.7M | 13,260,971 | -1.12pp | 29q | HELD | |
| BRIGHTVIEW HLDGS INC | BV | $308.9M | 21,533,123 | +0.59pp | 31q | HELD | |
| CRESCENT ENERGY COMPANY | CRGY | $281.4M | 28,655,357 | -2.31pp | 16q | HELD | |
| NIQ GLOBAL INTELLIGENCE PLC | NIQ | $280.7M | 30,022,789 | -1.47pp | 4q | HELD | |
| GMR SOLUTIONS INC | GMRS | $228.6M | 14,785,611 | - | new | NEW | |
| KKR REAL ESTATE FIN TR INC | KREF | $68.4M | 10,000,001 | +0.05pp | 31q | HELD | |
| PARAMOUNT SKYDANCE CORP | PSKY | $54.6M | 5,535,928 | +0.02pp | 4q | HELD | |
| NCL CORP LTD | $48.7M | 43,658,000 | - | new | DEBT | ||
| BAUSCH HEALTH COS INC | BHC | $25.8M | 5,235,000 | -0.08pp | 25q | HELD | |
| LCI INDS | $17.5M | 15,587,000 | +0.17pp | 2q | DEBT | ||
| FIRSTENERGY CORP | $16.4M | 15,000,000 | - | new | DEBT | ||
| AKAMAI TECHNOLOGIES INC | $16.3M | 11,151,000 | - | new | DEBT | ||
| OXFORD LANE CAP CORP | OXLC | $15.5M | 1,771,302 | -0.31pp | 2q | -44.4%-$12.4M | |
| IMMUNOCORE HLDGS PLC | $14.8M | 16,080,000 | -0.08pp | 6q | DEBT | ||
| BLACKSTONE MORTGAGE TRUST IN | $12.9M | 12,922,000 | +0.03pp | 3q | DEBT | ||
| PPL CAP FDG INC | $11.5M | 10,160,000 | -0.03pp | 7q | DEBT | ||
| CLOUDFLARE INC | $11.2M | 8,875,000 | - | new | DEBT | ||
| FS KKR CAP CORP | FSK | $10.3M | 980,587 | -0.01pp | 25q | HELD | |
| WEC ENERGY GROUP INC | $9.9M | 8,000,000 | -0.01pp | 4q | DEBT | ||
| SABRE GLBL INC | $8.7M | 8,613,000 | -0.10pp | 6q | DEBT | ||
| WINNEBAGO INDS INC | $8.6M | 9,251,000 | +0.10pp | 6q | DEBT | ||
| REDFIN CORP | $8.1M | 8,357,000 | +0.01pp | 5q | DEBT | ||
| JD.COM INC | $7.9M | 8,000,000 | +0.01pp | 2q | DEBT | ||
| TEMPUS AI INC | TEM | $6.8M | 117,652 | +0.02pp | 4q | HELD | |
| NORTHERN OIL & GAS INC | $6.0M | 6,244,000 | -0.29pp | 4q | DEBT | ||
| NORWEGIAN CRUISE LINE HLDGS | NCLH | $5.8M | 273,736 | +0.01pp | 6q | HELD | |
| STATE STR SPDR S&P 500 ETF T | SPY | $4.4M | 5,920 | - | new | NEW | |
| COHERUS ONCOLOGY INC | CHRS | $4.2M | 3,036,076 | -0.02pp | 31q | HELD | |
| SNAP INC | $3.6M | 3,900,000 | flat | 6q | DEBT | ||
| DOORDASH INC | $2.9M | 2,970,000 | - | new | DEBT | ||
| MERITAGE HOMES CORP | $1.4M | 1,348,000 | -0.02pp | 5q | DEBT | ||
| MERIT MED SYS INC | $1.3M | 1,195,000 | - | new | DEBT | ||
| ALKAMI TECHNOLOGY INC | $1.3M | 1,310,000 | - | new | DEBT | ||
| COGENT BIOSCIENCES INC | $1.2M | 990,000 | flat | 3q | DEBT | ||
| LANTHEUS HLDGS INC | $1.2M | 808,000 | flat | 9q | DEBT | ||
| RUBRIK INC. | $1.2M | 1,142,000 | - | new | DEBT | ||
| JAZZ INVESTMENTS I LTD | $1.2M | 683,000 | -0.02pp | 4q | DEBT | ||
| GRANITE CONSTR INC | $1.2M | 555,000 | +0.01pp | 3q | DEBT | ||
| CHEESECAKE FACTORY INC | $1.2M | 902,000 | flat | 2q | DEBT | ||
| ALPHATEC HLDGS INC | $1.1M | 1,180,000 | - | new | DEBT | ||
| NUTANIX INC | $1.1M | 1,114,000 | -0.01pp | 3q | DEBT | ||
| AEROVIRONMENT INC | $1.0M | 1,086,000 | flat | 4q | DEBT | ||
| UNITY SOFTWARE INC | $1.0M | 915,000 | flat | 2q | DEBT | ||
| GOLAR LNG LTD | $992.6K | 870,000 | - | new | DEBT | ||
| ARROWHEAD PHARMACEUTICALS IN | $958.0K | 800,000 | flat | 2q | DEBT | ||
| OMNICELL COM | $927.6K | 873,000 | -0.01pp | 3q | DEBT | ||
| VARONIS SYS INC | $843.0K | 868,000 | -0.02pp | 4q | DEBT | ||
| INTEGER HLDGS CORP | $827.5K | 852,000 | - | new | DEBT | ||
| PATRICK INDS INC | $799.0K | 539,000 | flat | 14q | DEBT | ||
| MICROCHIP TECHNOLOGY INC. | $754.8K | 685,000 | flat | 3q | DEBT | ||
| BILL HOLDINGS INC | $753.7K | 870,000 | flat | 3q | DEBT | ||
| SNOWFLAKE INC | $743.7K | 420,000 | -0.01pp | 4q | DEBT | ||
| TRAVERE THERAPEUTICS INC | $709.0K | 382,000 | -0.01pp | 5q | DEBT | ||
| PARSONS CORP DEL | $682.5K | 692,000 | -0.02pp | 6q | DEBT | ||
| SYNAPTICS INC | $651.2K | 438,000 | +0.01pp | 3q | DEBT | ||
| BRIDGEBIO PHARMA INC | $648.5K | 385,000 | - | new | DEBT | ||
| ENOVIS CORPORATION | $647.8K | 672,000 | -0.01pp | 7q | DEBT | ||
| PROGRESS SOFTWARE CORP | $631.5K | 657,000 | -0.01pp | 6q | DEBT | ||
| UBER TECHNOLOGIES INC | $623.0K | 520,000 | flat | 2q | DEBT | ||
| DATADOG INC | $598.1K | 420,000 | -0.01pp | 3q | DEBT | ||
| GUIDEWIRE SOFTWARE INC | $572.7K | 595,000 | flat | 3q | DEBT | ||
| SOLARIS ENERGY INFRAS INC | $570.1K | 350,000 | flat | 3q | DEBT | ||
| GLOBAL PMTS INC | $567.0K | 630,000 | flat | 6q | DEBT | ||
| SPECTRUM BRANDS INC | $562.0K | 538,000 | -0.01pp | 5q | DEBT | ||
| UGI CORP NEW | $556.0K | 415,000 | -0.02pp | 5q | DEBT | ||
| BLACKLINE INC | $553.8K | 600,000 | flat | 5q | DEBT | ||
| LIVE NATION ENTERTAINMENT IN | $550.2K | 460,000 | flat | 3q | DEBT | ||
| OSI SYSTEMS INC | $501.4K | 375,000 | flat | 4q | DEBT | ||
| IRHYTHM HOLDINGS INC | $495.7K | 450,000 | flat | 4q | DEBT | ||
| AKAMAI TECHNOLOGIES INC | $494.6K | 415,000 | -0.01pp | 8q | DEBT | ||
| RIVIAN AUTOMOTIVE INC | $475.1K | 445,000 | - | new | DEBT | ||
| MKS INC. | $474.5K | 161,000 | -0.02pp | 5q | DEBT | ||
| TRAVERE THERAPEUTICS INC | $471.0K | 400,000 | - | new | DEBT | ||
| VSE CORP | VSECU | $461.4K | 8,000 | flat | 2q | HELD | |
| ENVISTA HOLDINGS CORPORATION | $441.9K | 440,000 | -0.01pp | 6q | DEBT | ||
| LIVANOVA PLC | $402.0K | 295,000 | - | new | DEBT | ||
| FLUENCE ENERGY INC | $398.2K | 310,000 | flat | 3q | DEBT | ||
| HAEMONETICS CORP MASS | $381.9K | 376,000 | -0.01pp | 4q | DEBT | ||
| MIRUM PHARMACEUTICALS INC | $348.0K | 94,000 | -0.01pp | 9q | DEBT | ||
| CELCUITY INC | $344.6K | 153,000 | -0.01pp | 4q | DEBT | ||
| CELCUITY INC | $342.4K | 300,000 | - | new | DEBT | ||
| ON SEMICONDUCTOR CORP | $332.1K | 275,000 | -0.04pp | 10q | DEBT | ||
| FLUOR CORP | $325.1K | 245,000 | - | new | DEBT | ||
| ITRON INC | $321.5K | 322,000 | -0.02pp | 5q | DEBT | ||
| LIBERTY MEDIA CORP DEL | $317.7K | 256,000 | -0.01pp | 5q | DEBT | ||
| PAGERDUTY INC | $314.7K | 335,000 | -0.01pp | 7q | DEBT | ||
| REVOLUTION MEDICINES INC | $313.6K | 250,000 | - | new | DEBT | ||
| BENTLEY SYS INC | $279.7K | 291,000 | -0.01pp | 6q | DEBT | ||
| WEC ENERGY GROUP INC | $275.4K | 265,000 | - | new | DEBT | ||
| SOUTHERN CO | $273.1K | 270,000 | - | new | DEBT | ||
| WILLIS LEASE FIN CORP | $272.0K | 250,000 | - | new | DEBT | ||
| ALARM COM HLDGS INC | $256.9K | 270,000 | flat | 5q | DEBT | ||
| SHIFT4 PMTS INC | $253.1K | 265,000 | flat | 4q | DEBT | ||
| SNAP INC | $249.3K | 305,000 | -0.01pp | 5q | DEBT | ||
| WORKIVA INC | $244.6K | 261,000 | flat | 8q | DEBT | ||
| LEMAITRE VASCULAR INC | $212.6K | 200,000 | flat | 3q | DEBT | ||
| PAR TECHNOLOGY CORP | $202.3K | 250,000 | flat | 2q | DEBT |
By sector
Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.
| Sector | Value | Share |
|---|---|---|
| Healthcare Services | $1.9B | 32.8% |
| Wholesale & Distribution | $1.3B | 22.9% |
| Biotech & Pharma | $1.0B | 17.8% |
| Agriculture | $308.9M | 5.4% |
| Software & IT Services | $287.5M | 5.0% |
| Energy | $281.4M | 4.9% |
| Other sectors | $159.5M | 2.8% |
| Not classified | $475.6M | 8.3% |
What the disclosed book did
This is not the fund's return. A 13F shows long US equity positions only, so shorts, bonds, foreign listings, private holdings and cash are all invisible here. What this measures is the quarter's change in value of the positions this manager disclosed, had they been left untouched - the return a reader following the filing would have earned.
| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +23.2% | +14.8% | +8.4% | 95% |
| Q1 2026 | +2.9% | -4.6% | +7.5% | 94% |
| Q4 2025 | +17.8% | +2.4% | +15.4% | 93% |
| Q3 2025 | +9.5% | +7.8% | +1.7% | 91% |
| Q2 2025 | +21.8% | +10.5% | +11.3% | 88% |
| Q1 2025 | +5.3% | -4.6% | +9.9% | 84% |
| Q4 2024 | -4.3% | +2.1% | -6.5% | 88% |
| Q3 2024 | +18.7% | +5.4% | +13.2% | 80% |
Market is SPY over the same two quarter ends, priced the same way as everything else here - the median across every filer reporting it. It is a large-cap US proxy, so a manager holding small caps or biotech will beat or trail it for reasons that are not skill. Prices are quarter-end to quarter-end and say nothing about the path in between, or about trades opened and closed inside a quarter.
Quarter by quarter
| Quarter | Value | Positions | New | Added | Trimmed | Exited | Top 10 | Days to file |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | $5.7B | 99 | 23 | 7 | 32 | 16 | 95.2% | 45 |
| Q1 2026 | $5.3B | 92 | 11 | 4 | 19 | 10 | 95.1% | 45 |
| Q4 2025 | $6.3B | 91 | 16 | 9 | 16 | 10 | 94.0% | 48 |
| Q3 2025 | $6.0B | 85 | 23 | 29 | 14 | 14 | 93.5% | 45 |
| Q2 2025 | $4.8B | 76 | 17 | 17 | 11 | 16 | 94.3% | 45 |
| Q1 2025 | $4.4B | 75 | 20 | 4 | 18 | 13 | 93.9% | 45 |
| Q4 2024 | $3.7B | 68 | 10 | 9 | 26 | 14 | 92.1% | 45 |
| Q3 2024 | $7.5B | 72 | 13 | 23 | 14 | 10 | 94.1% | 45 |
| Q2 2024 | $3.3B | 69 | 10 | 29 | 12 | 8 | 89.2% | 45 |
| Q1 2024 | $3.9B | 67 | 8 | 11 | 22 | 12 | 86.2% | 45 |
| Q4 2023 | $3.4B | 71 | 9 | 11 | 20 | 11 | 81.5% | 45 |
| Q3 2023 | $2.8B | 73 | 12 | 24 | 11 | 10 | 81.5% | 114 |
| Q2 2023 | $3.2B | 71 | 7 | 15 | 13 | 18 | 83.4% | 45 |
| Q1 2023 | $3.3B | 82 | 12 | 13 | 15 | 56 | 83.7% | 45 |
| Q4 2022 | $3.0B | 126 | 19 | 16 | 2 | 106 | 78.9% | 45 |
| Q3 2022 | $5.0B | 213 | 13 | 5 | 22 | 63 | 84.9% | 45 |
| Q2 2022 | $7.5B | 263 | 14 | 36 | 16 | 27 | 87.4% | 43 |
| Q1 2022 | $11.0B | 276 | 107 | 93 | 28 | 39 | 88.0% | 46 |
| Q4 2021 | $18.2B | 208 | 50 | 67 | 53 | 27 | 93.4% | 45 |
| Q3 2021 | $20.1B | 185 | 77 | 61 | 26 | 33 | 92.7% | 46 |
| Q2 2021 | $24.7B | 141 | 72 | 28 | 20 | 32 | 90.9% | 47 |
| Q1 2021 | $19.8B | 101 | 57 | 5 | 13 | 16 | 90.7% | 47 |
| Q4 2020 | $19.7B | 60 | 9 | 7 | 8 | 14 | 90.5% | 47 |
| Q3 2020 | $17.5B | 65 | 18 | 8 | 7 | 20 | 90.6% | 47 |
| Q2 2020 | $16.4B | 67 | 26 | 3 | 7 | 9 | 91.6% | 45 |
| Q1 2020 | $15.7B | 50 | 8 | 6 | 11 | 12 | 95.3% | 45 |
| Q4 2019 | $20.5B | 54 | 12 | 3 | 4 | 10 | 94.4% | 45 |
| Q3 2019 | $17.8B | 52 | 11 | 2 | 8 | 14 | 94.2% | 45 |
| Q2 2019 | $8.1B | 55 | 11 | 5 | 6 | 11 | 85.4% | 45 |
| Q1 2019 | $6.6B | 55 | 13 | 6 | 9 | 14 | 83.8% | 45 |
| Q4 2018 | $5.5B | 56 | 0 | 0 | 0 | 0 | 79.6% | 44 |
Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.
Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.
Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.